• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Callisto Pharmaceuticals Inc



Callisto Pharmaceuticals Inc (CLSP:US) was acquired by SGYP:US

Company Profile

Callisto Pharmaceuticals Inc. is a drug development company focused on the clinical development of drugs to treat cancer. The company's most advanced drug candidate is Annamycin, an anthracycline for the treatment of relapsed leukemias. Callisto's other products being developed include Atiprimod, for relapsed multiple myeloma and bone resorption.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...
sec ||= nil